로고
About us
Company overview
History
Leadership
Business Strategy
Contact us
Core Technology
Antibody Discovery
Bispecific Antibody
Platform
Development Capability
Pipeline
Overview
IMB-101/102
IMB-201
IMB-301
IMB-401
Media Room
Notice
News
Gallery
Careers
Culture
Recruiting Information
언어선택
ENG
KOR
ENG
전체메뉴
About us
Company overview
History
Leadership
Business Strategy
Contact us
Core Technology
Antibody Discovery
Bispecific Antibody
Platform
Development Capability
Pipeline
Overview
IMB-101/102
IMB-201
IMB-301
IMB-401
Media Room
Notice
News
Gallery
Careers
Culture
Recruiting Information
Gallery
Innovative Medicines based on
ImmunoModulatory Biologics
Media Room
About us
Core Technology
Pipeline
Media Room
Careers
Gallery
Notice
News
Gallery
IMBiologics
Date
2022-04-06 10:19:43
View
722
첨부파일
IMBiologics.jpg
Prev
There's no previous post.
Next
IMBiologics, MOU with Canton Biologics
목록
President(CEO) : Gyongsik Ha
260, Changnyong-daero, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea